Patrik Jeanmonod - Aug 1, 2022 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Chief Financial Officer
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Patrik Jeanmonod
Stock symbol
CTKB
Transactions as of
Aug 1, 2022
Transactions value $
-$44,800
Form type
4
Date filed
8/3/2022, 05:49 PM
Previous filing
May 20, 2022
Next filing
Aug 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Sale -$44.8K -3.5K -3.55% $12.80 95K Aug 1, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.62 to $12.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Includes 1,071 shares acquired by the Reporting Person under the Issuer's 2021 Employee Stock Purchase Plan on May 31, 2022.